AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,910 | +52.5% | 181,500 | +22.4% | 0.00% | – |
| Q2 2023 | $135,663 | +115.2% | 148,265 | +31.8% | 0.00% | – |
| Q1 2023 | $63,045 | -10.1% | 112,500 | -7.5% | 0.00% | – |
| Q4 2022 | $70,161 | -45.6% | 121,597 | -70.3% | 0.00% | – |
| Q3 2022 | $129,000 | -42.9% | 408,774 | -36.1% | 0.00% | – |
| Q2 2022 | $226,000 | -70.6% | 639,603 | -40.3% | 0.00% | – |
| Q1 2022 | $769,000 | -51.2% | 1,071,497 | +53.7% | 0.00% | – |
| Q4 2021 | $1,576,000 | +62.6% | 696,997 | +107.1% | 0.00% | – |
| Q3 2021 | $969,000 | -48.3% | 336,598 | -32.0% | 0.00% | – |
| Q2 2021 | $1,876,000 | -9.5% | 494,920 | -19.2% | 0.00% | – |
| Q1 2021 | $2,074,000 | -39.6% | 612,715 | -50.1% | 0.00% | -100.0% |
| Q4 2020 | $3,436,000 | +113.3% | 1,227,161 | +91.3% | 0.00% | – |
| Q3 2020 | $1,611,000 | +4.7% | 641,529 | +466.0% | 0.00% | – |
| Q2 2020 | $1,539,000 | -25.5% | 113,342 | -58.4% | 0.00% | -100.0% |
| Q1 2020 | $2,065,000 | -65.3% | 272,481 | -71.1% | 0.00% | -50.0% |
| Q4 2019 | $5,952,000 | +309.6% | 941,820 | +154.0% | 0.00% | +100.0% |
| Q3 2019 | $1,453,000 | +192.4% | 370,750 | +261.6% | 0.00% | – |
| Q2 2019 | $497,000 | +87.5% | 102,532 | +216.0% | 0.00% | – |
| Q1 2019 | $265,000 | -96.7% | 32,446 | -97.7% | 0.00% | -100.0% |
| Q4 2018 | $7,961,000 | -12.5% | 1,439,742 | +39.7% | 0.00% | 0.0% |
| Q3 2018 | $9,100,000 | +39.0% | 1,030,476 | +57.1% | 0.00% | +33.3% |
| Q2 2018 | $6,548,000 | +181.4% | 655,936 | +168.7% | 0.00% | +200.0% |
| Q1 2018 | $2,327,000 | +929.6% | 244,114 | +1506.0% | 0.00% | – |
| Q4 2017 | $226,000 | -28.3% | 15,200 | -5.0% | 0.00% | – |
| Q3 2017 | $315,000 | +7.1% | 16,000 | -21.8% | 0.00% | – |
| Q2 2017 | $294,000 | -51.2% | 20,470 | -68.8% | 0.00% | -100.0% |
| Q1 2017 | $603,000 | +47.4% | 65,585 | +66.9% | 0.00% | – |
| Q4 2016 | $409,000 | +111.9% | 39,296 | +52.2% | 0.00% | – |
| Q2 2016 | $193,000 | +1.6% | 25,818 | +22.3% | 0.00% | – |
| Q1 2016 | $190,000 | -69.2% | 21,119 | -66.9% | 0.00% | -100.0% |
| Q3 2015 | $616,000 | +608.0% | 63,802 | +654.0% | 0.00% | – |
| Q2 2015 | $87,000 | -75.9% | 8,462 | -54.1% | 0.00% | – |
| Q1 2014 | $361,000 | – | 18,448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |